ArmeenMahvashMD

Radiology • Houston, TX

Interventional Neuroradiology, Vascular & Interventional Radiology

Physician

Join to view full profile

Dr. Mahvash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mahvash's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Summary

Dr. Armeen Mahvash is a radiologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Baylor College of Medicine and has been in practice 18 years. He specializes in vascular & interventional radiology.

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Vascular and Interventional Radiology, 2005 - 2006
University of Texas Health Science Center at HoustonResidency, Radiology-Diagnostic, 2000 - 2004
John Peter Smith Hospital (Tarrant County Hospital District)Internship, Transitional Year, 1999 - 2000
Baylor College of MedicineClass of 1999

Certifications & Licensure

TX State Medical License 2004 - 2026
American Board of Radiology Interventional Radiology and Diagnostic Radiology

Clinical Trials

Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma Start of enrollment: 2010 Aug 04
Completed
Not Applicable
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
Completed
Not Applicable
Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer Start of enrollment: 2017 Jan 09
Active, not recruiting
Phase 1
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D) Start of enrollment: 2019 Oct 10
Active, not recruiting
Not Applicable
Roles: Contact, Principal Investigator
Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients Start of enrollment: 2021 May 28
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning Start of enrollment: 2023 Mar 14
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

209 citations
Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases ...
Junichi Shindoh, Mark J. Truty, Thomas A. Aloia, Steven A. Curley, Giuseppe Zimmitti
Journal of the American College of Surgeons. 2013-02-01
91 citations
Safety and Efficacy of Portal Vein Embolization Before Planned Major or Extended Hepatectomy: An Institutional Experience of 358 Patients
Junichi Shindoh, Ching Wei D. Tzeng, Thomas A. Aloia, Steven A. Curley, Steven Y. Huang
Journal of Gastrointestinal Surgery. 2014-01-01
171 citations
Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with...
Junichi Shindoh, Jean Nicolas Vauthey, Giuzeppe Zimmitti, Steven A. Curley, Steven Y. Huang
Journal of the American College of Surgeons. 2013-07-01

Press Mentions

Sirtex Commences DOORwaY-90 Study for SIR-Spheres Therapy as First-Line Treatment of Unresectable HCCMay 10th, 2021
Sirtex Medical Announces New SIR-Spheres(R) DOORwaY-90 Study: The First Prospective Multicenter U.S.-based Trial for Registration as First-Line Treatment for Hepatocellular CarcinomaMarch 22nd, 2021

Professional Memberships

Society of Interventional Radiology - SIR
Member